Skip to main content

Table 4 Summary of adverse events (AE)

From: Randomized, placebo-controlled, double-blind trial of Swedish snus for smoking reduction and cessation

  Snus group, n = 158 (%) Placebo group, n = 161 (%)
Any AE 42 (26.6) 26 (16.1)
SAE 1 (0.6) 0
AE leading to discontinuation of study treatment 2 (1.3) 0
Treatment-related AE 30 (19.0) 18 (11.2)
  1. SAE: serious adverse event, Treatment-related: relation to allocated study treatment considered by the trialist to be possible, probable, or definite,